COR:NYE-CoreSite Realty Corporation (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 291.97

Change

-0.15 (-0.05)%

Market Cap

USD 2.35B

Volume

1.39M

Analyst Target

USD 128.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CoreSite Realty Corp is a fully integrated, self-administered and self-managed real estate investment trust. The Company is engaged in the business of owning, acquiring, constructing and managing technology-related real estate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
CAH Cardinal Health Inc

+0.26 (+0.17%)

USD 32.54B
MCK McKesson Corporation

+5.45 (+0.77%)

N/A
NVG Nuveen AMT Free Municipal Cred..

-0.07 (-0.59%)

N/A
OMI Owens & Minor Inc

-0.43 (-6.25%)

N/A

ETFs Containing COR

CWS AdvisorShares Focused Equ.. 4.99 % 0.68 %

+0.02 (+0.73%)

USD 0.17B
CUDV:CA CI U.S. Minimum Downside .. 4.87 % 0.00 %

-0.28 (0.73%)

CAD 4.96M
FXG First Trust Consumer Stap.. 4.38 % 0.64 %

+0.16 (+0.73%)

USD 0.32B
SAMT The Advisorsa€™ Inner C.. 3.85 % 0.00 %

+0.23 (+0.73%)

USD 0.12B
FCSG:LSE FIRST TRUST GLOBAL FUNDS .. 2.37 % 0.00 %

-27.00 (0.73%)

USD 0.06B
RSPH Invesco S&P 500 Equal Wei.. 2.08 % 0.00 %

-0.08 (0.73%)

USD 0.75B
GQI Natixis ETF Trust 1.79 % 0.00 %

-0.34 (0.73%)

USD 0.14B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 1.72 % 0.00 %

-0.80 (0.73%)

USD 0.29B
WDMVO:SW 1.66 % 0.00 %

N/A

N/A
IWP iShares Russell Mid-Cap G.. 1.61 % 0.24 %

-0.73 (0.73%)

USD 16.21B
IQSA:F Invesco Markets II PLC - .. 1.48 % 0.00 %

N/A

N/A
IQSE:F Invesco Quantitative Stra.. 1.48 % 0.00 %

N/A

N/A
MVEC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

-0.03 (0.73%)

USD 0.17B
MVEW:LSE iShares Edge MSCI World M.. 1.42 % 0.00 %

-0.04 (0.73%)

USD 0.50B
MVEW:SW iShares Edge MSCI World M.. 1.36 % 0.00 %

-0.06 (0.73%)

USD 0.50B
MVWE:SW iShares Edge MSCI World M.. 1.36 % 0.00 %

N/A

USD 0.07B
PAPI Morgan Stanley ETF Trust 0.65 % 0.00 %

-0.13 (0.73%)

USD 0.19B
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.41 % 0.00 %

-0.05 (0.73%)

USD 2.73B
DEUS Xtrackers Russell US Mult.. 0.00 % 0.18 %

-0.22 (0.73%)

USD 0.16B
JHMM John Hancock Multifactor .. 0.00 % 0.44 %

-0.13 (0.73%)

USD 3.62B
JPME JPMorgan Diversified Retu.. 0.00 % 0.24 %

-0.19 (0.73%)

USD 0.33B
PGAL 0.00 % 0.57 %

N/A

N/A
PPH VanEck Pharmaceutical ETF 0.00 % 0.36 %

+0.12 (+0.73%)

USD 0.71B
DVOL First Trust Dorsey Wright.. 0.00 % 0.60 %

+0.01 (+0.73%)

USD 0.07B
TPLC Timothy Plan US Large/Mid.. 0.00 % 0.00 %

-0.14 (0.73%)

USD 0.32B
MUMC-B:CA Manulife Multifactor U.S... 0.00 % 0.00 %

-0.09 (0.73%)

CAD 0.05B
VOE Vanguard Mid-Cap Value In.. 0.00 % 0.07 %

-0.28 (0.73%)

USD 17.96B
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

-1.40 (0.73%)

USD 9.87M
CD47:XETRA 0.00 % 0.00 %

N/A

N/A
ALTL Pacer Lunt Large Cap Alte.. 0.00 % 0.00 %

+0.04 (+0.73%)

USD 0.13B
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

-0.04 (0.73%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.95% 100% F 97% N/A
Dividend Return 0.24% 33% F 7% C-
Total Return 30.19% 100% F 97% N/A
Trailing 12 Months  
Capital Gain 30.32% 60% D- 92% A
Dividend Return 0.70% 50% F 13% F
Total Return 31.02% 60% D- 91% A-
Trailing 5 Years  
Capital Gain 139.18% 60% D- 83% B
Dividend Return 7.35% 40% F 15% F
Total Return 146.53% 60% D- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 19.22% 60% D- 83% B
Dividend Return 20.74% 60% D- 82% B
Total Return 1.53% 60% D- 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.73% 100% F 62% D
Risk Adjusted Return 131.85% 80% B- 99% N/A
Market Capitalization 2.35B 100% F 96% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 47.80 50% 14%
Price/Book Ratio 245.15 50% 1%
Price / Cash Flow Ratio 15.94 50% 23%
Price/Free Cash Flow Ratio 18.81 50% 17%
Management Effectiveness  
Return on Equity 198.15% 100% 100%
Return on Invested Capital 32.24% 50% 94%
Return on Assets 2.86% 50% 56%
Debt to Equity Ratio 590.11% 50% 5%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.